Results:
We included 20 patients with shingle. The sex ratio (M/F) was 0.8. The
median age was 68.5 years. Nine patients were over 70 years of age. The
administered vaccines were an mRNA vaccine for 15 patients. The onset
delay ranged between one and 30 days (mean of 4.5 days). All patients
recovered within a few days and no severe cases have been reported. Two
patients received the second dose; One patient did not experience a
recurrence of the symptomatology. The other patient, had aggravation of
symptomatology and occurrence of facial paralysis; noting that the
initial symptomatology did not entirely disappear when the patient
received the second dose. The patient was diagnosed with Ramsay Hunt
Syndrome.